Relation Between Atherosclerotic Calcifications Detected in Chest Computed Tomography and Lung Function;Relación entre las calcificaciones ateroscleróticas en el tórax detectadas mediante tomografía computarizada y la función pulmonar

Archivos de Bronconeumologia

Volumn 45, Issue 8, 2009, Pages 376-382

  Vehmas, Tapio ^a   Hiltunen, Asta ^b   Leino Arjas, Päivi ^a   Piirilä, Päivi ^c  

^a Instituto Finlandés de Salud Ocupacional   (Finland)

^b Lansi Pohja Central Hospital   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Respiratory function tests; Tomography spiral computed

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FORCED EXPIRATORY VOLUME; HUMAN; IMAGE ANALYSIS; LUNG CALCIFICATION; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL CANCER; SMOKING; TOTAL LUNG CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; ASBESTOSIS; ATHEROSCLEROSIS; CALCINOSIS; CORONARY ARTERY DISEASE; HEART VALVE DISEASES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY VENTILATION; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY;

EID: 67650639035     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2008.12.006     Document Type: Article

References (29)

1. Zureik M., Benetos A., Neukirch C., Courbon D., Bean K., Thomas F., et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med 164 (2001) 2181-2185
2. Schroeder E.B., Welch V.L., Couper D., Nieto F.J., Liao D., Rosamond W.D., et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 158 (2003) 1171-1181
3. Hozawa A., Billings J.L., Shahar E., Ohira T., Rosamond W.D., and Folsom A.R. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest 130 (2006) 1642-1649
4. Engström G., Hedblad B., and Janzon L. Reduced lung function predicts increased fatality in future cardiac events. A population-based study. J Intern Med 260 (2006) 560-567
5. Taneda K., Namekata T., Hughes D., Suzuki K., Knopp R., and Ozasa K. Association of lung function with atherosclerotic risk factors among Japanese Americans: Seattle Nikkei Health Study. Clin Exp Pharmacol Physiol 31 Suppl 2 (2004) 31-34
6. Tiitola M., Kivisaari L., Huuskonen M.S., Mattson K., Koskinen H., Lehtola H., et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 35 (2002) 17-22
7. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung, volumes and forced ventilatory flows. Eur Respir J 6 Suppl 16 (1993) 5-40
8. Cotes J.E., Chinn D.J., Quanjer P.D., Roca J., and Yearnault J.-C. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 6 Suppl 16 (1993) 41-52
9. Hilpert P. The change of the diffusion capacity of the lung for CO due to the haemoglobin concentration of the blood. Respiration 28 (1971) 518-525
10. Viljanen A.A. Reference values for spirometric, pulmonary diffusing capacity and body plethysmographic studies. Scand J Clin Invest 42 Suppl 159 (1982) 1-50
11. Hiltunen A., Kivisaari L., Leino-Arjas P., and Vehmas T. Scoring chest atherosclerosis in chest CT examinations: findings among male construction workers. Acta Radiol 49 (2008) 328-336
12. Han M.K., McLaughlin V.V., Criner G.J., and Martínez F.J. Pulmonary diseases and the heart. Circulation 116 (2007) 2992-3005
13. Bang K.M., Gergen P.J., Kramer R., and Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 103 (1993) 536-540
14. Mannino D.M., Buist A.S., Petty T.L., Enright P.L., and Redd S.C. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58 (2003) 388-393
15. Enright P.L., Kronmal R.A., Smith V.-E., Gardin J.M., Schenker M.B., and Manolio T.A. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. Chest 107 (1995) 28-35
16. Hancox R.J., Poulton R., Greene J.M., Filsell S., McLachlan C.R., Rasmussen F., et al. Systemic inflammation and lung function in young adults. Thorax 62 (2007) 1064-1068
17. Gan W.Q., Man S.F.P., Senthilsevan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax 59 (2004) 574-580
18. Wu T.L., Chang P.Y., Tsao K.C., Sun C.F., Wu L.L., and Wu J.T. A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal 21 (2007) 367-371
19. Maclay J.D., McAllister D.A., and Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 12 (2007) 634-641
20. Uflacker R., Kaemmerer A., Picon P.D., Rizzon C.F., Neves C.M., Oliveira E.S., et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology 157 (1985) 637-644
21. Hartmann I.J., Remy-Jardin M., Menchini L., Teisseire A., Khalil C., and Remy J. Ectopic origin of bronchial arteries: assessment with multidetector helical CT angiography. Eur Radiol 17 (2007) 1943-1953
22. Ventemiglia R.A., Braverman B., Di Mauro J., Castro R., Blair W., Spigos D., et al. The ischemic lung: role of the bronchial arteries in lung function. Cardiovasc Dis 8 (1981) 480-498
23. Gade J., Qvortrup K., Andersen C.B., Thorsen S., Svendsen U.G., and Olsen P.S. Bronchial arterial devascularization. An experimental study in pigs. Scand Cardiovasc J 35 (2001) 212-220
24. Walter R.E., Beiser A., Givelber R.J., O'Connor G.T., and Gottlieb D.J. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 167 (2003) 911-916
25. Funk G.C., Doberer D., Petkov V., and Block L.H. Hyperglycemia, bronchial artery sclerosis, and lung function. Am J Respir Crit Care Med 169 (2004) 427
26. Pellegrino T., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 26 (2005) 948-968
27. Dujic Z., Tocilj J., and Saric M. Early detection of interstitial lung disease in asbestos exposed non-smoking workers by mid-expiratory flow rate and high resolution computed tomography. Br J Indust Med 48 (1991) 663-664
28. Yeh H.C., Punjabi N.M., Wang N.Y., Pankow J.S., Duncan B.B., Cox C.E., et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 31 (2008) 741-746
29. De Lucas-Ramos P., Izquierdo-Alonso J.L., Rodríguez-González Moro J.M., Bellón-Cano J.M., Ancochea-Bermúdez J., Calle-Rubio M., et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study. Arch Bronconeumol 44 (2008) 233-238